BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bae JP, Lage MJ, Mo D, Nelson DR, Hoogwerf BJ. Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011. J Diabetes Complications. 2016;30:212-220. [PMID: 26689451 DOI: 10.1016/j.jdiacomp.2015.11.016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Lilly CM, Swami S, Liu X, Riker RR, Badawi O. Five-Year Trends of Critical Care Practice and Outcomes. Chest 2017;152:723-35. [PMID: 28800866 DOI: 10.1016/j.chest.2017.06.050] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
2 Antal B, McMahon LP, Sultan SF, Lithen A, Wexler DJ, Dickerson B, Ratai EM, Mujica-Parodi LR. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses. Elife 2022;11:e73138. [PMID: 35608247 DOI: 10.7554/eLife.73138] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Boye KS, Lage MJ, Shinde S, Thieu V, Bae JP. Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012-2019. Diabetes Ther 2021;12:2077-87. [PMID: 34076849 DOI: 10.1007/s13300-021-01084-0] [Reference Citation Analysis]
4 Chetoui A, Kaoutar K, Elmoussaoui S, Boutahar K, El Kardoudi A, Chigr F, Najimi M. Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients. Int Health 2020:ihz107. [PMID: 31957782 DOI: 10.1093/inthealth/ihz107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Modesto ACF, Silveira EA, dos Santos Rodrigues AP, Lima DM, Provin MP, Amaral RG. Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial. Sci Pharm 2020;88:48. [DOI: 10.3390/scipharm88040048] [Reference Citation Analysis]
6 Abdullah A, Alkandari A, Longenecker JC, Devarajan S, Alkhatib A, Al-wotayan R, Al-duwairi Q, Tuomilehto J. Glycemic control in Kuwaiti diabetes patients treated with glucose-lowering medication. Primary Care Diabetes 2020;14:311-6. [DOI: 10.1016/j.pcd.2019.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Urina-Jassir M, Herrera-Parra LJ, Hernández Vargas JA, Valbuena-García AM, Acuña-Merchán L, Urina-Triana M. The effect of comorbidities on glycemic control among Colombian adults with diabetes mellitus: a longitudinal approach with real-world data. BMC Endocr Disord 2021;21:128. [PMID: 34174843 DOI: 10.1186/s12902-021-00791-w] [Reference Citation Analysis]
8 Qaddoumi M, Al-Khamis Y, Channanath A, Tuomilehto J, Badawi D. The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait. Front Endocrinol (Lausanne) 2019;10:412. [PMID: 31297092 DOI: 10.3389/fendo.2019.00412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Takahara M, Katakami N, Shiraiwa T, Abe K, Ayame H, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O, Yokoyama H, Matsuoka TA, Shimomura I. Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L. Acta Diabetol 2019;56:309-19. [PMID: 30353354 DOI: 10.1007/s00592-018-1244-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Al-Eitan LN, Nassar AM, Saadeh NA, Almomani BA. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan. Can J Diabetes 2016;40:496-502. [PMID: 27212046 DOI: 10.1016/j.jcjd.2016.04.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
11 Kim YJ, Hwang SD, Lim S. Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis. Front Endocrinol (Lausanne) 2020;11:553. [PMID: 32973680 DOI: 10.3389/fendo.2020.00553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zaman SB, Hossain N, Rahman M. Associations between Body Mass Index and Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients: Findings from the Northeast of Thailand. Diabetes Metab J 2018;42:330-7. [PMID: 30136452 DOI: 10.4093/dmj.2017.0052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hashimoto K, Urata K, Yoshida A, Horiuchi R, Yamaaki N, Yagi K, Arai K. The relationship between patients' perception of type 2 diabetes and medication adherence: a cross-sectional study in Japan. J Pharm Health Care Sci 2019;5:2. [PMID: 30693091 DOI: 10.1186/s40780-019-0132-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
14 Doddamani P, Ramanathan N, Swetha NK, Suma MN. Comparative Assessment of ADA, IDRS, and FINDRISC in Predicting Prediabetes and Diabetes Mellitus in South Indian Population. J Lab Physicians 2021;13:36-43. [PMID: 34054237 DOI: 10.1055/s-0041-1727557] [Reference Citation Analysis]
15 Alderisio A, Bozzetto L, Franco L, Riccardi G, Rivellese AA, Annuzzi G. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study. Nutr Metab Cardiovasc Dis 2019;29:1110-7. [PMID: 31371264 DOI: 10.1016/j.numecd.2019.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lara-Esqueda A, Zaizar-Fregoso SA, Madrigal-Perez VM, Ramirez-Flores M, Montes-Galindo DA, Martinez-Fierro ML, Rodriguez-Sanchez IP, Guzman-Esquivel J, Meza-Robles C, Ceja-Espiritu G, Kuri-Morales PA, Delgado-Enciso J, Barriguete-Melendez A, Galvan-Salazar HR, Barajas-Saucedo CE, Guillermo-Espinosa E, Lara-Basulto AD, Gonzalez-Roldan JF, Delgado-Enciso I. Evaluation of Medical Care for Diabetic and Hypertensive Patients in Primary Care in Mexico: Observational Retrospective Study. J Diabetes Res 2021;2021:7365075. [PMID: 34426789 DOI: 10.1155/2021/7365075] [Reference Citation Analysis]
17 Sakboonyarat B, Pima W, Chokbumrungsuk C, Pimpak T, Khunsri S, Ukritchon S, Imjaijitt W, Mungthin M, Kaewput W, Bhopdhornangkul B, Sathavarodom N, Tatsanavivat P, Rangsin R. National trends in the prevalence of glycemic control among patients with type 2 diabetes receiving continuous care in Thailand from 2011 to 2018. Sci Rep 2021;11:14260. [PMID: 34253809 DOI: 10.1038/s41598-021-93733-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Chiang JI, Jani BD, Mair FS, Nicholl BI, Furler J, O'Neal D, Jenkins A, Condron P, Manski-Nankervis JA. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review. PLoS One 2018;13:e0209585. [PMID: 30586451 DOI: 10.1371/journal.pone.0209585] [Cited by in Crossref: 13] [Article Influence: 3.3] [Reference Citation Analysis]
19 Alzaheb RA, Altemani AH. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes Metab Syndr Obes 2018;11:15-21. [PMID: 29430192 DOI: 10.2147/DMSO.S156214] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
20 Krepel Volsky S, Shalitin S, Fridman E, Yackobovitch-Gavan M, Lazar L, Bello R, Oron T, Tenenbaum A, de Vries L, Lebenthal Y. Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: A single-center experience. World J Diabetes 2021; 12(1): 56-68 [PMID: 33520108 DOI: 10.4239/wjd.v12.i1.56] [Reference Citation Analysis]
21 Melaku T, Chelkeba L, Mekonnen Z, Kumela K. Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming  Co-Epidemics. Diabetes Metab Syndr Obes 2020;13:4379-99. [PMID: 33235478 DOI: 10.2147/DMSO.S266105] [Reference Citation Analysis]
22 Pathiraja NP, Colman PG, Wentworth JM. Glycaemic trajectory and predictors of suboptimal glycaemic control in people with type 2 diabetes. Intern Med J 2020;50:1415-8. [PMID: 33215839 DOI: 10.1111/imj.15059] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Cheng LJ, Wang W, Lim ST, Wu VX. Factors associated with glycaemic control in patients with diabetes mellitus: A systematic literature review. J Clin Nurs 2019;28:1433-50. [PMID: 30667583 DOI: 10.1111/jocn.14795] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
24 Özkaya V, Eren E, Özgen Özkaya Ş, Denkboy Öngen Y. Prevalence of obesity in prepubertal and pubertal with Turkish population type 1 diabetes. Diabetol Int 2021;12:412-9. [PMID: 34567924 DOI: 10.1007/s13340-021-00498-2] [Reference Citation Analysis]
25 Branyan TE, Sohrabji F. Sex differences in stroke co-morbidities. Exp Neurol 2020;332:113384. [PMID: 32585156 DOI: 10.1016/j.expneurol.2020.113384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
26 Sheleme T, Mamo G, Melaku T, Sahilu T. Glycemic Control and its Predictors among Adult Diabetic Patients attending Mettu Karl Referral Hospital, Southwest Ethiopia: A Prospective Observational Study. Diabetes Ther 2020;11:1775-94. [PMID: 32583174 DOI: 10.1007/s13300-020-00861-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hepsen S, Sencar E, Sakiz D, Akhanli P, Ucan B, Unsal I, Ozbek M, Cakal E. Serum cortisol level after low dose dexamethasone suppression test may be predictive for diabetes mellitus and hypertension presence in obese patients: A retrospective study. Diabetes Res Clin Pract 2020;161:108081. [PMID: 32068098 DOI: 10.1016/j.diabres.2020.108081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Magnusson L, Espes D, Casas R, Carlsson PO. Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases. Front Immunol 2020;11:1916. [PMID: 32983115 DOI: 10.3389/fimmu.2020.01916] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Dubé MC, D'Amours M, Weisnagel SJ. Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetes. Diabetes Obes Metab 2020;22:1417-24. [PMID: 32250534 DOI: 10.1111/dom.14050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Franco L, Bozzetto L, Angelis R, Calabrese I, Cavagnuolo L, Gasparro T, Riccardi G, Rivellese AA, Annuzzi G. Beneficial effects on body weight of group vs individual care in adults with type 1 diabetes on advanced technologies. Health Sci Rep 2021;4:e385. [PMID: 34622019 DOI: 10.1002/hsr2.385] [Reference Citation Analysis]
31 Wehner MR, Micheletti R, Noe MH, Linos E, Margolis DJ, Naik HB. Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions. J Am Acad Dermatol 2020;82:1239-41. [PMID: 31866261 DOI: 10.1016/j.jaad.2019.12.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Mphasha MH, Skaal L, Mothiba TM. Prevalence of overweight and obesity amongst patients with diabetes and their non-diabetic family members in Senwabarwana, Limpopo province, South Africa. South African Family Practice 2022;64. [DOI: 10.4102/safp.v64i1.5409] [Reference Citation Analysis]
33 Boye KS, Shinde S, Kennedy-Martin T, Robinson S, Thieu VT. Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review. Patient Prefer Adherence 2022;16:23-39. [PMID: 35023906 DOI: 10.2147/PPA.S328583] [Reference Citation Analysis]
34 Boye KS, Lage MJ, Thieu V, Shinde S, Dhamija S, Bae JP. Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data. J Diabetes Complications 2021;35:107975. [PMID: 34176723 DOI: 10.1016/j.jdiacomp.2021.107975] [Reference Citation Analysis]
35 Papajorgji-Taylor D, Francisco M, Schneider JL, Vaughn K, Lindberg N, Smith N, Fitzpatrick SL. Bridge to Health/ Puente a la Salud: Rationale and design of a pilot feasibility randomized trial to address diabetes self-management and unmet basic needs among racial/ethnic minority and low-income patients. Contemp Clin Trials Commun 2021;22:100779. [PMID: 34013093 DOI: 10.1016/j.conctc.2021.100779] [Reference Citation Analysis]
36 Huang YH, Chen ST, Liu FH, Hsieh SH, Lin CH, Liou MJ, Wang CC, Huang CH, Liu GH, Lin JR, Yang LY, Hsu TY, Lee MC, Huang CT, Wu YH. The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial. PLoS One 2019;14:e0221199. [PMID: 31415655 DOI: 10.1371/journal.pone.0221199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
37 Ibrahim AO, Agboola SM, Elegbede OT, Ismail WO, Agbesanwa TA, Omolayo TA. Glycemic control and its association with sociodemographics, comorbid conditions, and medication adherence among patients with type 2 diabetes in southwestern Nigeria. J Int Med Res 2021;49:3000605211044040. [PMID: 34632841 DOI: 10.1177/03000605211044040] [Reference Citation Analysis]
38 Rodbard HW, Giaccari A, Cariou B, Garg S, Davies MJ, Seth K, Sawhney S. Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2. Diab Vasc Dis Res 2021;18:1479164121995928. [PMID: 33611925 DOI: 10.1177/1479164121995928] [Reference Citation Analysis]
39 Garvey WT, Birkenfeld AL, Dicker D, Mingrone G, Pedersen SD, Satylganova A, Skovgaard D, Sugimoto D, Jensen C, Mosenzon O. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care 2020;43:1085-93. [PMID: 32139381 DOI: 10.2337/dc19-1745] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
40 Wen WL, Wu PY, Huang JC, Tu HP, Chen SC. Different Curve Shapes of Fasting Glucose and Various Obesity-Related Indices by Diabetes and Sex. Int J Environ Res Public Health 2021;18:3096. [PMID: 33802865 DOI: 10.3390/ijerph18063096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Tino S, Mayanja BN, Mubiru MC, Eling E, Ddumba E, Kaleebu P, Nyirenda M. Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda-a descriptive retrospective study. BMJ Open 2020;10:e039258. [PMID: 33148749 DOI: 10.1136/bmjopen-2020-039258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Cheng LJ, Wu VX, Dawkes S, Lim ST, Wang W. Factors influencing diet barriers among outpatients with poorly-controlled type 2 diabetes: A descriptive correlational study. Nurs Health Sci 2019;21:102-11. [PMID: 30264523 DOI: 10.1111/nhs.12569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
43 Khawandanah J. Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors. Nutr Diabetes 2019;9:33. [PMID: 31685799 DOI: 10.1038/s41387-019-0101-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
44 Boye KS, Lage MJ, Terrell K. Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity. Journal of Diabetes and its Complications 2020;34:107730. [DOI: 10.1016/j.jdiacomp.2020.107730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Kang NH, Mukherjee S, Min T, Kang SC, Yun JW. Trans-anethole ameliorates obesity via induction of browning in white adipocytes and activation of brown adipocytes. Biochimie 2018;151:1-13. [PMID: 29803631 DOI: 10.1016/j.biochi.2018.05.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
46 Apperley LJ, Ng SM. Increased insulin requirement may contribute to risk of obesity in children and young people with Type 1 Diabetes Mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:492-5. [DOI: 10.1016/j.dsx.2018.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Isaacs D, Yager S, Parker M, Wolfe L, Luxenburg J, Lekic S. Adjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 Diabetes. Ann Pharmacother 2019;53:371-84. [PMID: 30499305 DOI: 10.1177/1060028018816728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
48 Shrestha S, Baser O, Kwong WJ. Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation. Ann Pharmacother 2018;52:147-53. [PMID: 28856898 DOI: 10.1177/1060028017728295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
49 Kuziemski K, Słomiński W, Jassem E. Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy persons. BMC Endocr Disord 2019;19:2. [PMID: 30606177 DOI: 10.1186/s12902-018-0328-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
50 Goldenberg RM, Steen O. Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes. Can J Diabetes 2019;43:136-45. [PMID: 30195966 DOI: 10.1016/j.jcjd.2018.05.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
51 Bawadi H, Al Sada A, Al Mansoori N, Al Mannai S, Hamdan A, Shi Z, Kerkadi A. Sleeping Duration, Napping and Snoring in Association with Diabetes Control among Patients with Diabetes in Qatar. Int J Environ Res Public Health 2021;18:4017. [PMID: 33921201 DOI: 10.3390/ijerph18084017] [Reference Citation Analysis]
52 Ichikawa H, Imoto H, Tanaka N, Musha H, Sawada S, Naitoh T, Kamei T, Unno M. Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report. Surg Case Rep 2021;7:7. [PMID: 33409743 DOI: 10.1186/s40792-020-00989-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Balasubramaniam S, Lim SL, Goh LH, Subramaniam S, Tangiisuran B. Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia. Diabetes Metab Syndr 2019;13:2585-91. [PMID: 31405680 DOI: 10.1016/j.dsx.2019.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Farhat R, Assaf J, Jabbour H, Licha H, Hajj A, Hallit S, Khabbaz LR. Adherence to oral glucose lowering drugs, quality of life, treatment satisfaction and illness perception: A cross-sectional study in patients with type 2 diabetes. Saudi Pharm J 2019;27:126-32. [PMID: 30662315 DOI: 10.1016/j.jsps.2018.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Lund A, Ebbing C, Rasmussen S, Qvigstad E, Kiserud T, Kessler J. Pre-gestational diabetes: Maternal body mass index and gestational weight gain are associated with augmented umbilical venous flow, fetal liver perfusion, and thus birthweight. PLoS One 2021;16:e0256171. [PMID: 34398922 DOI: 10.1371/journal.pone.0256171] [Reference Citation Analysis]
56 Guyton J, Jeon M, Brooks A. Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus. Am J Health Syst Pharm 2019;76:1739-48. [PMID: 31612934 DOI: 10.1093/ajhp/zxz179] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ito F, Sono Y, Ito T. Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants (Basel) 2019;8:E72. [PMID: 30934586 DOI: 10.3390/antiox8030072] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 26.0] [Reference Citation Analysis]
58 Chetoui A, Kaoutar K, Boutahar K, El Kardoudi A, Elmoussaoui S, Chigr F, Najimi M. Prevalence of overweight/obesity and its associated factors among a sample of Moroccan type 2 diabetes patients. Afr Health Sci 2021;21:23-31. [PMID: 34394277 DOI: 10.4314/ahs.v21i1.5] [Reference Citation Analysis]
59 Zhu HT, Yu M, Hu H, He QF, Pan J, Hu RY. Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study. BMC Endocr Disord 2019;19:57. [PMID: 31170961 DOI: 10.1186/s12902-019-0384-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
60 Rahman M, Nakamura K, Hasan SMM, Seino K, Mostofa G. Mediators of the association between low socioeconomic status and poor glycemic control among type 2 diabetics in Bangladesh. Sci Rep 2020;10:6690. [PMID: 32317650 DOI: 10.1038/s41598-020-63253-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Karatas S, Beysel S. Visceral Adiposity Index, Triglyceride/High-Density Lipoprotein Ratio, and Lipid Accumulation Product Index to Discriminate Metabolic Syndrome Among Adult Type 1 Diabetes Patients. Metab Syndr Relat Disord 2021. [PMID: 34283922 DOI: 10.1089/met.2021.0047] [Reference Citation Analysis]